MENU
ALKS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Alkermes (ALKS) Ownership - Who owns Alkermes?
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
1 Burlington Road
Phone
+353 17728000
Employees
2100
Web
https://www.alkermes.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
4.55B
P/E Ratio
8.90
Total Cash
773.49M
Projected Growth
N/A
Total Debt
372.19M
Revenue
1.66B
Risk (Beta)
0.38
Dividend Yield
N/A
Total Cash/Share
4.63
Total Debt/Equity
27.09
Revenue/Share
9.80 USD as % of share price
Fundamentals
ALKS
Capitalization
4.55B
P/E Ratio
8.90
Risk (Beta)
0.38
Dividend Yield
N/A
Total Cash
773M
Total Cash/Share
4.63
Total Debt
372M
Total Debt/Equity
27.09
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
9.80%
Revenue
1.66B
ROE
N/A
Book Value
1.2B
P/B Ratio
3.78
Cash Flow
N/A
Earnings
2.14
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.73M
Current Ratio
2.86
Current Revenue Per Employee
179750.00
Dividends Per Share - Security
N/A
EBITDA
519M
Float
N/A
Float - Current
N/A
Gross Income Margin
81.43
Revenue To Assets
17.35
Shares Held By Institutions
14.1B
Shares Outstanding - Current
167M
Total Liabilities
934M
Total Volume MTD
N/A
Value
-1
Gain YTD
10.083
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of pharmaceutical products
Industry PharmaceuticalsOther
Profile
Fundamentals
Details
Industry
Biotechnology
Address
1 Burlington Road
Phone
+353 17728000
Employees
2100
Web
https://www.alkermes.com